Unique gene signature could help predict response to chemotherapy

byThe Francis Crick InstituteIn vitro anticancer drug screen. a Volcano plots showing differences in IC50 values between RAS high and low CCLE cell lines. Drugs with enriched target annotations

Updated on: December 20,2023

Unique gene signature could help predict response to chemotherapy

byThe Francis Crick InstituteIn vitro anticancer drug screen. a Volcano plots showing differences in IC50 values between RAS high and low CCLE cell lines. Drugs with enriched target annotations

Updated on:December 20,2023

Patient-derived Organoids: Revolutionizing Cancer Research and Treatment

Updated on: November 14,2024

Patient-derived Organoids: Revolutionizing Cancer Research and Treatment

Updated on:November 14,2024

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on: August 12,2024

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on:August 12,2024

Marker found for condition that causes numerous tumors

by Cathy Frisinger,UT Southwestern Medical CenterCutaneous neurofibromas cover the back of a patient. Credit: UTSWUT Southwestern researchers have made a major advance in uncovering the biology

Updated on: December 18,2023

Marker found for condition that causes numerous tumors

by Cathy Frisinger,UT Southwestern Medical CenterCutaneous neurofibromas cover the back of a patient. Credit: UTSWUT Southwestern researchers have made a major advance in uncovering the biology

Updated on:December 18,2023

Distinguishing fatal prostate cancer from 'manageable' cancer now possible

byUniversity of YorkScientists at the University of York have found a way of distinguishing between fatal prostate cancer and manageable cancer, which could reduce unnecessary surgeries and radi

Updated on: December 18,2023

Distinguishing fatal prostate cancer from 'manageable' cancer now possible

byUniversity of YorkScientists at the University of York have found a way of distinguishing between fatal prostate cancer and manageable cancer, which could reduce unnecessary surgeries and radi

Updated on:December 18,2023

New way to determine whether metastatic cancer cells in breast cancer patients are dormant or soon to turn deadly

byThe Mount Sinai HospitalFor the first time ever, Mount Sinai researchers have identified a protein as a marker that can indicate whether a cancer patient will develop a reoccurrence of lethal,

Updated on: December 18,2023

New way to determine whether metastatic cancer cells in breast cancer patients are dormant or soon to turn deadly

byThe Mount Sinai HospitalFor the first time ever, Mount Sinai researchers have identified a protein as a marker that can indicate whether a cancer patient will develop a reoccurrence of lethal,

Updated on:December 18,2023

Cancer patients can now use skin creams during radiation therapy

byPerelman School of Medicine at the University of PennsylvaniaCancer patients can now use skin creams during radiation therapy. Credit: Penn MedicineContrary to the advice most cancer patients

Updated on: December 18,2023

Cancer patients can now use skin creams during radiation therapy

byPerelman School of Medicine at the University of PennsylvaniaCancer patients can now use skin creams during radiation therapy. Credit: Penn MedicineContrary to the advice most cancer patients

Updated on:December 18,2023

An anticancer drug opens a new path for the treatment of Parkinson's

by Spanish National Research CouncilGraphical abstract. Credit:Cell Chemical Biology(2024). DOI: 10.1016/j.chembiol.2024.01.007Once they enter the body, drugs, apart from carrying out

Updated on: May 21,2024

An anticancer drug opens a new path for the treatment of Parkinson's

by Spanish National Research CouncilGraphical abstract. Credit:Cell Chemical Biology(2024). DOI: 10.1016/j.chembiol.2024.01.007Once they enter the body, drugs, apart from carrying out

Updated on:May 21,2024

Scientists develop first bone marrow model that supports human stem cells

byUniversity of GlasgowSchematic of the bone marrow (BM) niche microenvironment. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-50054-0Scientists have created the first

Updated on: August 03,2024

Scientists develop first bone marrow model that supports human stem cells

byUniversity of GlasgowSchematic of the bone marrow (BM) niche microenvironment. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-50054-0Scientists have created the first

Updated on:August 03,2024

Incidence of early-onset gastric cancer increasing in the U.S.

(HealthDay)—The incidence of early-onset gastric cancer has been increasing in the United States, and it seems to be distinct clinically and genetically from late-onset gastric cancer, according to a

Updated on: December 22,2023

Incidence of early-onset gastric cancer increasing in the U.S.

(HealthDay)—The incidence of early-onset gastric cancer has been increasing in the United States, and it seems to be distinct clinically and genetically from late-onset gastric cancer, according to a

Updated on:December 22,2023

Three-drug combination therapy effective in patients with high-risk chronic lymphocytic leukemia, trial shows

byDana-Farber Cancer InstituteNew research shows that genetics account for only five to 10 per cent of risk for most human diseases, and that gene testing is a poor predictor of whether someone

Updated on: January 04,2024

Three-drug combination therapy effective in patients with high-risk chronic lymphocytic leukemia, trial shows

byDana-Farber Cancer InstituteNew research shows that genetics account for only five to 10 per cent of risk for most human diseases, and that gene testing is a poor predictor of whether someone

Updated on:January 04,2024

IBIS-II study finds anastrozole reduces breast cancer rates for high risk postmenopausal women

byQueen Mary, University of LondonCredit: CC0 Public DomainThe Queen Mary University of London professor leading an international breast cancer study says anastrozole—rather than tamoxifen—shoul

Updated on: December 22,2023

IBIS-II study finds anastrozole reduces breast cancer rates for high risk postmenopausal women

byQueen Mary, University of LondonCredit: CC0 Public DomainThe Queen Mary University of London professor leading an international breast cancer study says anastrozole—rather than tamoxifen—shoul

Updated on:December 22,2023